| 1 |
31740151 | Paricalcitol regulatory effect on inflammatory, fibrotic and anticalcificating parameters in renal patiente. Far beyond mineral bone disease regulation. | 2020 Mar - Apr |
1 |
| 2 |
26700731 | Vitamin D modulates tissue factor and protease-activated receptor 2 expression in vascular smooth muscle cells. | 2016 Mar |
1 |
| 3 |
26451144 | Role of Paricalcitol in Modulating the Immune Response in Patients with Renal Disease. | 2015 |
1 |
| 4 |
24511210 | Selective vitamin D receptor activation as anti-inflammatory target in chronic kidney disease. | 2014 |
1 |
| 5 |
23335378 | Paricalcitol effects on activities and metabolism of platelet activating factor and on inflammatory cytokines in hemodialysis patients. | 2013 Feb |
1 |
| 6 |
23186077 | Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients. | 2012 Nov 27 |
1 |
| 7 |
19259778 | Paricalcitol reduces basal and lipopolysaccharide-induced (LPS) TNF-alpha and IL-8 production by human peripheral blood mononuclear cells. | 2010 Mar |
3 |
| 8 |
20736134 | Paricalcitol, a synthetic vitamin D analog: a candidate for combination therapy with biological agents in rheumatoid arthritis. | 2010 Dec |
1 |
| 9 |
18525004 | Paricalcitol inhibits renal inflammation by promoting vitamin D receptor-mediated sequestration of NF-kappaB signaling. | 2008 Sep |
1 |